We found that the number of circulating EPCs increased in tumor-bearing mice compared to tumor-free mice and that disruption of Ccl2 and Ccr2 had profound effects on circulating EPC numbers: EPCs were greatly reduced in Ccl2-/- mice and increased in Ccr2-/- mice. The gene discussed is CCL2; the disease is neoplasm.